“A Repurposed Duo: Empagliflozin-Metformin Triggers a Metabolic Crisis in Cervical Cancer by Disrupting the Acyl-CoA CoA Ratio via Dual Inhibition of PPAT and CPT1A”. Journal of Cancer Research Updates 14 (December 31, 2025): 247–265. Accessed May 24, 2026. https://mail.neoplasiaresearch.com/index.php/jcru/article/view/922.